Home Articles List Article Information
Medical Journal of Viral Hepatitis
Journal Archive
Volume Volume 9.1 (2025)
Volume Volume 8.2 (2024)
Volume Volume 8.1 (2024)
Volume Volume 7.3 (2023)
Volume Volume 7.2 (2023)
Volume Volume 7.1 (2022)
Volume Volume 6.3 (2022)
Volume Volume 6.2 (2022)
Volume Volume 6.1 (2021)
Volume Volume 5.3 (2021)
Volume Volume 5.2 (2021)
Volume Volume 5.1 (2020)
Volume Volume 4.2 (2020)
Volume Volume 4.1 (2019)
Volume Volume 3.2 (2019)
Volume Volume 3.1 (2018)
Volume Volume 2.2 (2018)
Volume Volume 2.1 (2016)
Volume Volume 1.2 (2016)
Volume Volume 1.1 (2015)
Ezzat, A., Elmoghazy, M. (2021). Metabolic dysfunction-associated fatty liver disease from definition to complications. Medical Journal of Viral Hepatitis, 6.1(1), 4-9. doi: 10.21608/mjvh.2021.211705
Ahmed Ezzat; Mohammad Elmoghazy. "Metabolic dysfunction-associated fatty liver disease from definition to complications". Medical Journal of Viral Hepatitis, 6.1, 1, 2021, 4-9. doi: 10.21608/mjvh.2021.211705
Ezzat, A., Elmoghazy, M. (2021). 'Metabolic dysfunction-associated fatty liver disease from definition to complications', Medical Journal of Viral Hepatitis, 6.1(1), pp. 4-9. doi: 10.21608/mjvh.2021.211705
Ezzat, A., Elmoghazy, M. Metabolic dysfunction-associated fatty liver disease from definition to complications. Medical Journal of Viral Hepatitis, 2021; 6.1(1): 4-9. doi: 10.21608/mjvh.2021.211705

Metabolic dysfunction-associated fatty liver disease from definition to complications

Article 2, Volume 6.1, Issue 1, December 2021, Page 4-9  XML PDF (584.53 K)
Document Type: Review articles
DOI: 10.21608/mjvh.2021.211705
View on SCiNiTO View on SCiNiTO
Authors
Ahmed Ezzat email 1; Mohammad Elmoghazy2
1Tropical medicine department, Mansoura faculty of medicine
2Damietta Cardiology and Gastroenterology Center, Damietta, Egypt.
Abstract
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a novel term to describe new diagnostic criteria for diagnosing fatty liver disease free of alcohol intake and associated viral hepatitis infection. These new diagnostic criteria, make it easier to diagnose than non-alcoholic fatty liver disease (NAFLD). Although we may not have a lot of studies about MAFLD yet, we have plenty of evidence about IR, metabolic syndrome and dysfunction, and NAFLD. In this review, we try to spotlight some important and updated knowledge about MAFLD and its related conditions, to help us better understand and deal with this global problem.
Keywords
Metabolic dysfunction-associated fatty liver disease; non-alcoholic fatty liver disease; insulin resistance
Statistics
Article View: 241
PDF Download: 1,721